Robin Roberts, COO and co-founder of the Novartis Biome, was on site at JP Morgan last month in San Francisco, but we weren’t able to pin him down for an interview.
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<